Regeneron Pharmaceuticals (REGN) Dividend Yield, Date & History $633.84 -27.16 (-4.11%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Dividend Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Regeneron Pharmaceuticals Dividend SummaryDividend Yield0.14%Annual Dividend$0.88Recent Dividend Payment Mar. 20 Dividend Payout Ratio 2.30% Regeneron Pharmaceuticals (REGN) pays an annual dividend of $0.88 per share, with a dividend yield of 0.14%. The next n/a payment of $0.88 per share was paid on Thursday, March 20, to investors who owned the stock before the ex-dividend date of Thursday, February 20. The company currently pays out 2.30% of its earnings and 2.11% of its cash flow as dividends. Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Enter your email to sign up for newsletter Sign Up Skip Charts & View Dividend HistoryREGN Dividend Payments by QuarterDividend Payments by Quarter Chart DescriptionThe chart below displays up to four years of Regeneron Pharmaceuticals' dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.Open Regeneron Pharmaceuticals in Dividend Calculator REGN Dividend Yield Over TimeDividend Yield Over Time Chart DescriptionThe chart below tracks Regeneron Pharmaceuticals' dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.Open Regeneron Pharmaceuticals in Dividend Yield Calculator Remove Ads Regeneron Pharmaceuticals vs. The CompetitionCompare Regeneron Pharmaceuticals' annual dividend, yield, and 3-year growth rate with averages for Medical and NASDAQ companies to evaluate its performance against the market.TypeRegeneron PharmaceuticalsMedical CompaniesNASDAQ CompaniesAnnual Dividend$0.88$0.05$1.26Dividend Yield0.14%4.55%4.02%Annualized 3-Year Dividend Growth0.00%5.58%12.10%Regeneron Pharmaceuticals Dividend Payout RatioDividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.TypePayout RatioBased on Trailing 12 Months of Earnings2.30%Based on This Year's Estimate2.45%Based on Next Year's Estimate2.31%Based on Cashflow2.11% Regeneron Pharmaceuticals Dividend History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years All Time Time Frame * Start Date * End Date AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date2/20/2025quarterly$0.88 - 0.53%2/20/20252/20/20253/20/2025This table shows Regeneron Pharmaceuticals' dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time. Remove Ads Regeneron Pharmaceuticals Dividend - Frequently Asked Questions What is Regeneron Pharmaceuticals's dividend yield? The current dividend yield for Regeneron Pharmaceuticals is 0.14%. Learn more on REGN's dividend yield history. How much is Regeneron Pharmaceuticals's annual dividend? The annual dividend for REGN shares is $0.88. Learn more on REGN's annual dividend history. How often does Regeneron Pharmaceuticals pay dividends? Regeneron Pharmaceuticals pays n/a dividends to shareholders. What is Regeneron Pharmaceuticals's dividend payout ratio? The dividend payout ratio for REGN is: 2.30% based on the trailing year of earnings 2.45% based on this year's estimates 2.31% based on next year's estimates 2.11% based on cash flow Is Regeneron Pharmaceuticals a good dividend stock? Regeneron Pharmaceuticals' dividend yield of 0.13% is lower than the average Medical company that issues a dividend. Regeneron Pharmaceuticals' dividend payout ratio of 2.30% is at a healthy, sustainable level, below 75% of its earnings. Looking at the stock as a whole, market analysts rate Regeneron Pharmaceuticals stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation. More Dividend Resources from MarketBeat Related Companies Amgen Dividend Yield Gilead Sciences Dividend Yield Dominari Dividend Yield Dividend Tools Dividend Announcements Dividend Calculator Dividend Capture Stocks Dividend Cuts Dividend Increases Dividend Investing Guide Dividend Newsletter Dividend Payout Ratio Calculator Dividend Screener Dividend Stocks Overview Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Special Dividends Stock Lists Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles Top Dividend Stocks With Over 10 Years of Hikes—and Room to GrowDividend Boosters: 3 Industry Leaders Increasing Dividend PayoutsThese 3 Dividend Stocks Jumped 15% in a Month—More to Come?AAON Doubles Down: Dividend Raise & Share Buyback PlanWarren Buffett Swaps VOO for This Reliable Dividend StockThese 3 Stocks Grew Dividends +50% Annually Over the Last 3 YearsWin-Win Momentum Plays With Strong Dividend YieldsLowe’s Stock Eyes New Highs as Growth, Dividends Drive Gains3 Dividend-Paying Stocks Bucking the Market’s Trend More Dividend News Remove Ads This page (NASDAQ:REGN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy REGN Stock Free REGN Stock Alerts